Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECONSIDER
NCT03371784Phase 3Unknown
- Sponsor
- Iuliu Hațieganu University of Medicine and Pharmacy
- Start
- Mar 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in ST-segment elevation myocardial infarction (STEMI), Left ventricular remodeling (LVR), sponsored by Iuliu Hațieganu University of Medicine and Pharmacy. Status: unknown.
02
Drugs
hydrocortisone
03
Conditions
ST-segment elevation myocardial infarction (STEMI)Left ventricular remodeling (LVR)
Beyond the preview
Go deeper on NCT03371784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371784.